Report Categories Report Categories

Report Categories

industry Category

All

Total: 4 records, 1 pages

Global Myotonic Dystrophy Therapeutics Supply, Demand and Key Producers, 2024-2030

date 18 Feb 2024

date Pharma & Healthcare

new_biaoQian Myotonic Dystrophy Therapeutics

The global Myotonic Dystrophy Therapeutics market size is expected to reach $ 73 million by 2030, rising at a market growth of 6.1% CAGR during the forecast period (2024-2030).

USD4480.00

Add To Cart

Add To Cart

Global Myotonic Dystrophy Therapeutics Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 09 Jan 2024

date Pharma & Healthcare

new_biaoQian Myotonic Dystrophy Therapeutics

According to our (Global Info Research) latest study, the global Myotonic Dystrophy Therapeutics market size was valued at USD 48 million in 2023 and is forecast to a readjusted size of USD 73 million by 2030 with a CAGR of 6.1% during review period.

USD3480.00

Add To Cart

Add To Cart

Global Myotonic Dystrophy Therapeutics Supply, Demand and Key Producers, 2023-2029

date 25 Feb 2023

date Pharma & Healthcare

new_biaoQian Myotonic Dystrophy Therapeutics

The global Myotonic Dystrophy Therapeutics market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

USD4480.00

Add To Cart

Add To Cart

Global Myotonic Dystrophy Therapeutics Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 09 Jan 2023

date Pharma & Healthcare

new_biaoQian Myotonic Dystrophy Therapeutics

Myotonic dystrophy is a type of muscular dystrophy, a group of long-term genetic disorders that impair muscle function. Symptoms include gradually worsening muscle loss and weakness. Muscles often contract and are unable to relax. Other symptoms may include cataracts, intellectual disability and heart conduction problems. In men, there may be early balding and an inability to have children.

USD3480.00

Add To Cart

Add To Cart

industry 18 Feb 2024

industry Pharma & Healthcare

new_biaoQian Myotonic Dystrophy Therapeutics

The global Myotonic Dystrophy Therapeutics market size is expected to reach $ 73 million by 2030, rising at a market growth of 6.1% CAGR during the forecast period (2024-2030).

USD4480.00

addToCart

Add To Cart

industry 09 Jan 2024

industry Pharma & Healthcare

new_biaoQian Myotonic Dystrophy Therapeutics

According to our (Global Info Research) latest study, the global Myotonic Dystrophy Therapeutics market size was valued at USD 48 million in 2023 and is forecast to a readjusted size of USD 73 million by 2030 with a CAGR of 6.1% during review period.

USD3480.00

addToCart

Add To Cart

industry 25 Feb 2023

industry Pharma & Healthcare

new_biaoQian Myotonic Dystrophy Therapeutics

The global Myotonic Dystrophy Therapeutics market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

USD4480.00

addToCart

Add To Cart

industry 09 Jan 2023

industry Pharma & Healthcare

new_biaoQian Myotonic Dystrophy Therapeutics

Myotonic dystrophy is a type of muscular dystrophy, a group of long-term genetic disorders that impair muscle function. Symptoms include gradually worsening muscle loss and weakness. Muscles often contract and are unable to relax. Other symptoms may include cataracts, intellectual disability and heart conduction problems. In men, there may be early balding and an inability to have children.

USD3480.00

addToCart

Add To Cart